Share Price and Basic Stock Data
Last Updated: January 2, 2026, 7:12 pm
| PEG Ratio | -3.38 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Deepak Nitrite Ltd, operating in the chemicals sector, reported a market capitalization of ₹23,325 Cr with a share price of ₹1,711. The company has exhibited a significant growth trajectory over the years, with sales rising from ₹1,327 Cr in FY 2015 to ₹7,972 Cr in FY 2023. However, the most recent fiscal year saw a slight decline in sales to ₹7,682 Cr in FY 2024, followed by a projected increase to ₹8,282 Cr in FY 2025. Quarterly sales figures show fluctuations, with ₹1,778 Cr in Q2 FY 2023 and a rise to ₹2,126 Cr in Q1 FY 2024, indicating seasonal trends. The company’s operational performance has been stable, with a reported operating profit margin (OPM) of 11% for FY 2024, down from 16% in FY 2023, reflecting cost pressures. The consistent revenue stream is bolstered by a diversified product portfolio, which includes key inorganic chemicals, positioning Deepak Nitrite as a robust player in the Indian chemical landscape.
Profitability and Efficiency Metrics
Deepak Nitrite reported a net profit of ₹532 Cr for FY 2025, a decline from ₹852 Cr in FY 2023 and ₹811 Cr in FY 2024. The company’s profitability metrics, including a return on equity (ROE) of 13.4% and a return on capital employed (ROCE) of 16.3%, reflect a moderate efficiency in utilizing shareholders’ funds and capital respectively. The operating profit stood at ₹1,095 Cr for FY 2025, with an OPM of 13%, indicating some operational challenges. The interest coverage ratio (ICR) at 42.75x highlights the company’s strong ability to meet its interest obligations, suggesting a stable financial footing. However, the reduction in net profit margins, which fell to 8.42% in FY 2025 from 10.68% in FY 2023, raises concerns about the sustainability of profitability amid rising input costs. The company’s effective management of expenses will be critical in maintaining profitability in the coming quarters.
Balance Sheet Strength and Financial Ratios
As of FY 2025, Deepak Nitrite’s balance sheet reflects a healthy financial position with total assets of ₹7,708 Cr and total borrowings of ₹1,244 Cr, indicating a debt-to-equity ratio of 0.21x, which is low compared to industry averages. The reserves stood at ₹5,488 Cr, showcasing the company’s ability to retain earnings and reinvest in growth opportunities. The current ratio of 3.57x suggests robust liquidity, ensuring that the company can comfortably meet its short-term obligations. However, the return on assets (ROA) of 9.03% indicates room for improvement in asset utilization. The price-to-book value (P/BV) ratio of 5.02x suggests that the stock may be overvalued relative to its book value, which could deter some value-oriented investors. Overall, while the balance sheet is strong, the company must focus on enhancing asset efficiency to maximize shareholder returns.
Shareholding Pattern and Investor Confidence
Deepak Nitrite’s shareholding pattern reveals a diverse ownership structure, with promoters holding 49.28% of the stake, indicating significant insider confidence. Foreign institutional investors (FIIs) hold 6.21%, while domestic institutional investors (DIIs) account for 22.70%, reflecting moderate institutional interest. The public holds 21.82% of the shares, which has seen a decline from 31.81% in December 2022, indicating a shift in retail investor sentiment. The total number of shareholders stood at 419,367 as of September 2025, showing a slight increase from the previous quarter, suggesting that the company remains attractive to new investors. The consistency in promoter holdings, coupled with a solid institutional base, enhances confidence in the company’s governance and strategic direction. However, the decline in public shareholding may raise concerns regarding retail investor engagement and market perception.
Outlook, Risks, and Final Insight
The outlook for Deepak Nitrite appears cautiously optimistic, driven by its strong position in the chemicals sector and ongoing revenue growth. However, risks such as fluctuating raw material costs and changing regulatory environments could impact profitability. The company’s ability to navigate these challenges while sustaining sales growth will be pivotal. Additionally, the recent trend of declining net profits and margins could pose risks to investor confidence. If the company can effectively manage its operational efficiencies and maintain robust cash flows, it may mitigate these risks and continue to deliver value to shareholders. On the other hand, failure to address cost pressures and enhance profitability could lead to a reassessment of its growth prospects. Ultimately, while the fundamentals remain strong, investors should closely monitor financial performance and market conditions to make informed decisions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Fischer Medical Ventures Ltd | 2,706 Cr. | 41.8 | 125/40.8 | 135 | 5.55 | 0.01 % | 1.08 % | 0.70 % | 1.00 |
| Emmessar Biotech & Nutrition Ltd | 15.0 Cr. | 30.0 | 46.6/25.8 | 65.2 | 16.0 | 0.00 % | 12.6 % | 4.23 % | 10.0 |
| Cochin Minerals & Rutile Ltd | 229 Cr. | 292 | 356/238 | 13.7 | 211 | 2.74 % | 23.3 % | 15.0 % | 10.0 |
| Archean Chemical Industries Ltd | 6,947 Cr. | 563 | 728/408 | 33.9 | 157 | 0.53 % | 16.0 % | 12.0 % | 2.00 |
| Alufluoride Ltd | 340 Cr. | 435 | 515/376 | 16.6 | 144 | 0.69 % | 23.6 % | 20.8 % | 10.0 |
| Industry Average | 5,038.75 Cr | 438.65 | 161.14 | 157.12 | 0.47% | 13.95% | 10.65% | 7.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,962 | 1,991 | 1,961 | 1,768 | 1,778 | 2,009 | 2,126 | 2,167 | 2,032 | 1,903 | 2,180 | 1,890 | 1,902 |
| Expenses | 1,691 | 1,676 | 1,613 | 1,559 | 1,476 | 1,705 | 1,825 | 1,858 | 1,734 | 1,735 | 1,863 | 1,700 | 1,698 |
| Operating Profit | 271 | 315 | 348 | 210 | 302 | 305 | 301 | 309 | 298 | 169 | 317 | 190 | 204 |
| OPM % | 14% | 16% | 18% | 12% | 17% | 15% | 14% | 14% | 15% | 9% | 15% | 10% | 11% |
| Other Income | 12 | 13 | 13 | 32 | 17 | 14 | 99 | 19 | 21 | 21 | 23 | 25 | 20 |
| Interest | 6 | 6 | 4 | 2 | 3 | 3 | 4 | 6 | 6 | 6 | 9 | 8 | 8 |
| Depreciation | 42 | 41 | 41 | 38 | 39 | 42 | 46 | 47 | 48 | 48 | 51 | 51 | 53 |
| Profit before tax | 235 | 281 | 315 | 202 | 277 | 274 | 349 | 275 | 264 | 135 | 279 | 155 | 163 |
| Tax % | 26% | 26% | 26% | 26% | 26% | 26% | 27% | 26% | 26% | 27% | 27% | 27% | 27% |
| Net Profit | 174 | 209 | 234 | 150 | 205 | 202 | 254 | 203 | 194 | 98 | 202 | 112 | 119 |
| EPS in Rs | 12.79 | 15.33 | 17.15 | 10.99 | 15.04 | 14.81 | 18.61 | 14.85 | 14.24 | 7.19 | 14.84 | 8.23 | 8.70 |
Last Updated: January 1, 2026, 11:32 pm
Below is a detailed analysis of the quarterly data for Deepak Nitrite Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 1,902.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,890.00 Cr. (Jun 2025) to 1,902.00 Cr., marking an increase of 12.00 Cr..
- For Expenses, as of Sep 2025, the value is 1,698.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,700.00 Cr. (Jun 2025) to 1,698.00 Cr., marking a decrease of 2.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 204.00 Cr.. The value appears strong and on an upward trend. It has increased from 190.00 Cr. (Jun 2025) to 204.00 Cr., marking an increase of 14.00 Cr..
- For OPM %, as of Sep 2025, the value is 11.00%. The value appears strong and on an upward trend. It has increased from 10.00% (Jun 2025) to 11.00%, marking an increase of 1.00%.
- For Other Income, as of Sep 2025, the value is 20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 25.00 Cr. (Jun 2025) to 20.00 Cr., marking a decrease of 5.00 Cr..
- For Interest, as of Sep 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 8.00 Cr..
- For Depreciation, as of Sep 2025, the value is 53.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 51.00 Cr. (Jun 2025) to 53.00 Cr., marking an increase of 2.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 163.00 Cr.. The value appears strong and on an upward trend. It has increased from 155.00 Cr. (Jun 2025) to 163.00 Cr., marking an increase of 8.00 Cr..
- For Tax %, as of Sep 2025, the value is 27.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 27.00%.
- For Net Profit, as of Sep 2025, the value is 119.00 Cr.. The value appears strong and on an upward trend. It has increased from 112.00 Cr. (Jun 2025) to 119.00 Cr., marking an increase of 7.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 8.70. The value appears strong and on an upward trend. It has increased from 8.23 (Jun 2025) to 8.70, marking an increase of 0.47.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:27 am
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,327 | 1,373 | 1,371 | 1,651 | 2,700 | 4,230 | 4,360 | 6,802 | 7,972 | 7,682 | 8,282 | 7,875 |
| Expenses | 1,187 | 1,204 | 1,231 | 1,447 | 2,278 | 3,194 | 3,108 | 5,196 | 6,680 | 6,555 | 7,187 | 6,996 |
| Operating Profit | 140 | 169 | 139 | 204 | 421 | 1,035 | 1,252 | 1,607 | 1,292 | 1,127 | 1,095 | 879 |
| OPM % | 11% | 12% | 10% | 12% | 16% | 24% | 29% | 24% | 16% | 15% | 13% | 11% |
| Other Income | 1 | -0 | 80 | 7 | 11 | 29 | 20 | 42 | 46 | 156 | 84 | 88 |
| Interest | 38 | 40 | 37 | 47 | 87 | 118 | 77 | 36 | 27 | 15 | 31 | 32 |
| Depreciation | 36 | 40 | 48 | 53 | 78 | 140 | 153 | 178 | 166 | 166 | 195 | 204 |
| Profit before tax | 67 | 89 | 135 | 111 | 268 | 806 | 1,042 | 1,434 | 1,146 | 1,102 | 953 | 732 |
| Tax % | 21% | 29% | 28% | 29% | 35% | 24% | 26% | 26% | 26% | 26% | 27% | |
| Net Profit | 53 | 63 | 96 | 79 | 174 | 611 | 776 | 1,067 | 852 | 811 | 697 | 532 |
| EPS in Rs | 5.06 | 5.39 | 7.37 | 5.79 | 12.73 | 44.80 | 56.88 | 78.20 | 62.47 | 59.45 | 51.12 | 38.96 |
| Dividend Payout % | 20% | 22% | 16% | 22% | 16% | 10% | 10% | 9% | 12% | 13% | 15% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 18.87% | 52.38% | -17.71% | 120.25% | 251.15% | 27.00% | 37.50% | -20.15% | -4.81% | -14.06% |
| Change in YoY Net Profit Growth (%) | 0.00% | 33.51% | -70.09% | 137.96% | 130.90% | -224.14% | 10.50% | -57.65% | 15.34% | -9.24% |
Deepak Nitrite Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 14% |
| 3 Years: | 7% |
| TTM: | -1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 2% |
| 3 Years: | -14% |
| TTM: | -25% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 41% |
| 5 Years: | 19% |
| 3 Years: | -5% |
| 1 Year: | -41% |
| Return on Equity | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 23% |
| 3 Years: | 17% |
| Last Year: | 13% |
Last Updated: September 5, 2025, 2:45 am
Balance Sheet
Last Updated: December 4, 2025, 1:09 am
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 21 | 23 | 26 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 |
| Reserves | 325 | 450 | 689 | 895 | 1,044 | 1,545 | 2,319 | 3,311 | 4,063 | 4,769 | 5,361 | 5,488 |
| Borrowings | 545 | 529 | 724 | 987 | 1,187 | 1,107 | 590 | 315 | 73 | 286 | 1,267 | 1,244 |
| Other Liabilities | 235 | 295 | 350 | 684 | 677 | 538 | 630 | 779 | 967 | 1,012 | 1,053 | 1,124 |
| Total Liabilities | 1,125 | 1,296 | 1,789 | 2,592 | 2,935 | 3,217 | 3,567 | 4,432 | 5,129 | 6,095 | 7,708 | 7,884 |
| Fixed Assets | 549 | 594 | 586 | 588 | 1,716 | 1,832 | 1,864 | 1,963 | 1,942 | 2,293 | 2,457 | 2,567 |
| CWIP | 44 | 36 | 349 | 955 | 34 | 172 | 220 | 122 | 301 | 774 | 1,649 | 2,046 |
| Investments | 3 | 87 | 118 | 32 | 2 | 2 | 189 | 439 | 379 | 122 | 511 | 303 |
| Other Assets | 530 | 580 | 736 | 1,018 | 1,183 | 1,210 | 1,293 | 1,908 | 2,508 | 2,907 | 3,091 | 2,967 |
| Total Assets | 1,125 | 1,296 | 1,789 | 2,592 | 2,935 | 3,217 | 3,567 | 4,432 | 5,129 | 6,095 | 7,708 | 7,884 |
Below is a detailed analysis of the balance sheet data for Deepak Nitrite Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 27.00 Cr..
- For Reserves, as of Sep 2025, the value is 5,488.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,361.00 Cr. (Mar 2025) to 5,488.00 Cr., marking an increase of 127.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,244.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 1,267.00 Cr. (Mar 2025) to 1,244.00 Cr., marking a decrease of 23.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,124.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,053.00 Cr. (Mar 2025) to 1,124.00 Cr., marking an increase of 71.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 7,884.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7,708.00 Cr. (Mar 2025) to 7,884.00 Cr., marking an increase of 176.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 2,567.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,457.00 Cr. (Mar 2025) to 2,567.00 Cr., marking an increase of 110.00 Cr..
- For CWIP, as of Sep 2025, the value is 2,046.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,649.00 Cr. (Mar 2025) to 2,046.00 Cr., marking an increase of 397.00 Cr..
- For Investments, as of Sep 2025, the value is 303.00 Cr.. The value appears to be declining and may need further review. It has decreased from 511.00 Cr. (Mar 2025) to 303.00 Cr., marking a decrease of 208.00 Cr..
- For Other Assets, as of Sep 2025, the value is 2,967.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,091.00 Cr. (Mar 2025) to 2,967.00 Cr., marking a decrease of 124.00 Cr..
- For Total Assets, as of Sep 2025, the value is 7,884.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,708.00 Cr. (Mar 2025) to 7,884.00 Cr., marking an increase of 176.00 Cr..
Notably, the Reserves (5,488.00 Cr.) exceed the Borrowings (1,244.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -405.00 | -360.00 | -585.00 | -783.00 | 420.00 | 0.00 | -589.00 | -314.00 | -72.00 | -285.00 | 0.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 86 | 83 | 96 | 91 | 78 | 53 | 63 | 61 | 60 | 62 | 56 |
| Inventory Days | 47 | 54 | 75 | 118 | 94 | 63 | 64 | 53 | 62 | 54 | 59 |
| Days Payable | 48 | 59 | 95 | 176 | 106 | 57 | 72 | 46 | 46 | 38 | 33 |
| Cash Conversion Cycle | 85 | 79 | 76 | 32 | 66 | 59 | 56 | 67 | 76 | 77 | 82 |
| Working Capital Days | -3 | -28 | -49 | -29 | 35 | 33 | 57 | 57 | 70 | 70 | 64 |
| ROCE % | 14% | 8% | 10% | 17% | 38% | 40% | 44% | 30% | 22% | 16% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Kotak Midcap Fund | 3,979,784 | 1.03 | 620.29 | N/A | N/A | N/A |
| Franklin India Small Cap Fund | 1,387,967 | 1.6 | 216.33 | N/A | N/A | N/A |
| Nippon India Small Cap Fund | 1,175,325 | 0.27 | 183.19 | 1,000,000 | 2025-12-08 02:35:59 | 17.53% |
| Franklin India Mid Cap Fund | 1,100,123 | 1.33 | 171.47 | N/A | N/A | N/A |
| Franklin India Focused Equity Fund | 767,769 | 0.93 | 119.66 | 767,769 | 2025-04-22 17:25:37 | 0% |
| ICICI Prudential Multicap Fund | 697,881 | 0.67 | 108.77 | N/A | N/A | N/A |
| Sundaram Mid Cap Fund | 687,834 | 0.8 | 107.21 | 517,174 | 2025-12-08 02:35:59 | 33% |
| Nippon India Growth Mid Cap Fund | 593,778 | 0.22 | 92.55 | N/A | N/A | N/A |
| Invesco India Contra Fund | 417,600 | 0.32 | 65.09 | N/A | N/A | N/A |
| Canara Robeco ELSS Tax Saver Fund | 410,000 | 0.7 | 63.9 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 51.12 | 59.45 | 62.46 | 78.20 | 56.88 |
| Diluted EPS (Rs.) | 51.12 | 59.45 | 62.46 | 78.20 | 56.88 |
| Cash EPS (Rs.) | 65.45 | 71.59 | 74.66 | 91.23 | 68.07 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 395.06 | 353.57 | 299.85 | 244.75 | 172.04 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 395.06 | 353.57 | 299.85 | 244.75 | 172.04 |
| Revenue From Operations / Share (Rs.) | 607.18 | 563.18 | 584.46 | 498.69 | 319.63 |
| PBDIT / Share (Rs.) | 86.19 | 87.93 | 98.02 | 120.69 | 93.00 |
| PBIT / Share (Rs.) | 71.87 | 75.79 | 85.83 | 107.66 | 81.81 |
| PBT / Share (Rs.) | 69.85 | 80.77 | 84.01 | 105.16 | 76.37 |
| Net Profit / Share (Rs.) | 51.13 | 59.45 | 62.46 | 78.20 | 56.88 |
| NP After MI And SOA / Share (Rs.) | 51.12 | 59.45 | 62.46 | 78.20 | 56.88 |
| PBDIT Margin (%) | 14.19 | 15.61 | 16.77 | 24.20 | 29.09 |
| PBIT Margin (%) | 11.83 | 13.45 | 14.68 | 21.58 | 25.59 |
| PBT Margin (%) | 11.50 | 14.34 | 14.37 | 21.08 | 23.89 |
| Net Profit Margin (%) | 8.42 | 10.55 | 10.68 | 15.68 | 17.79 |
| NP After MI And SOA Margin (%) | 8.41 | 10.55 | 10.68 | 15.68 | 17.79 |
| Return on Networth / Equity (%) | 12.93 | 16.90 | 20.83 | 31.95 | 33.06 |
| Return on Capital Employeed (%) | 14.42 | 19.46 | 27.00 | 39.86 | 37.11 |
| Return On Assets (%) | 9.03 | 13.30 | 16.61 | 24.07 | 21.79 |
| Long Term Debt / Equity (X) | 0.19 | 0.04 | 0.01 | 0.05 | 0.22 |
| Total Debt / Equity (X) | 0.21 | 0.04 | 0.01 | 0.09 | 0.24 |
| Asset Turnover Ratio (%) | 1.20 | 1.37 | 0.81 | 0.80 | 0.67 |
| Current Ratio (X) | 3.57 | 3.62 | 3.45 | 3.06 | 2.62 |
| Quick Ratio (X) | 2.57 | 2.65 | 2.33 | 2.28 | 1.93 |
| Inventory Turnover Ratio (X) | 9.82 | 6.67 | 3.81 | 4.20 | 3.02 |
| Dividend Payout Ratio (NP) (%) | 14.67 | 12.61 | 11.20 | 7.03 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 11.45 | 10.47 | 9.37 | 6.02 | 0.00 |
| Earning Retention Ratio (%) | 85.33 | 87.39 | 88.80 | 92.97 | 0.00 |
| Cash Earning Retention Ratio (%) | 88.55 | 89.53 | 90.63 | 93.98 | 0.00 |
| Interest Coverage Ratio (X) | 42.75 | 101.38 | 53.95 | 48.36 | 17.10 |
| Interest Coverage Ratio (Post Tax) (X) | 26.36 | 62.80 | 35.38 | 32.33 | 11.46 |
| Enterprise Value (Cr.) | 27844.67 | 28716.86 | 25144.18 | 30869.10 | 23144.91 |
| EV / Net Operating Revenue (X) | 3.36 | 3.74 | 3.15 | 4.54 | 5.31 |
| EV / EBITDA (X) | 23.68 | 23.94 | 18.81 | 18.75 | 18.25 |
| MarketCap / Net Operating Revenue (X) | 3.27 | 3.77 | 3.15 | 4.50 | 5.18 |
| Retention Ratios (%) | 85.32 | 87.38 | 88.79 | 92.96 | 0.00 |
| Price / BV (X) | 5.02 | 6.03 | 6.14 | 9.17 | 9.63 |
| Price / Net Operating Revenue (X) | 3.27 | 3.77 | 3.15 | 4.50 | 5.18 |
| EarningsYield | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 |
After reviewing the key financial ratios for Deepak Nitrite Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 51.12. This value is within the healthy range. It has decreased from 59.45 (Mar 24) to 51.12, marking a decrease of 8.33.
- For Diluted EPS (Rs.), as of Mar 25, the value is 51.12. This value is within the healthy range. It has decreased from 59.45 (Mar 24) to 51.12, marking a decrease of 8.33.
- For Cash EPS (Rs.), as of Mar 25, the value is 65.45. This value is within the healthy range. It has decreased from 71.59 (Mar 24) to 65.45, marking a decrease of 6.14.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 395.06. It has increased from 353.57 (Mar 24) to 395.06, marking an increase of 41.49.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 395.06. It has increased from 353.57 (Mar 24) to 395.06, marking an increase of 41.49.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 607.18. It has increased from 563.18 (Mar 24) to 607.18, marking an increase of 44.00.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 86.19. This value is within the healthy range. It has decreased from 87.93 (Mar 24) to 86.19, marking a decrease of 1.74.
- For PBIT / Share (Rs.), as of Mar 25, the value is 71.87. This value is within the healthy range. It has decreased from 75.79 (Mar 24) to 71.87, marking a decrease of 3.92.
- For PBT / Share (Rs.), as of Mar 25, the value is 69.85. This value is within the healthy range. It has decreased from 80.77 (Mar 24) to 69.85, marking a decrease of 10.92.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 51.13. This value is within the healthy range. It has decreased from 59.45 (Mar 24) to 51.13, marking a decrease of 8.32.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 51.12. This value is within the healthy range. It has decreased from 59.45 (Mar 24) to 51.12, marking a decrease of 8.33.
- For PBDIT Margin (%), as of Mar 25, the value is 14.19. This value is within the healthy range. It has decreased from 15.61 (Mar 24) to 14.19, marking a decrease of 1.42.
- For PBIT Margin (%), as of Mar 25, the value is 11.83. This value is within the healthy range. It has decreased from 13.45 (Mar 24) to 11.83, marking a decrease of 1.62.
- For PBT Margin (%), as of Mar 25, the value is 11.50. This value is within the healthy range. It has decreased from 14.34 (Mar 24) to 11.50, marking a decrease of 2.84.
- For Net Profit Margin (%), as of Mar 25, the value is 8.42. This value is within the healthy range. It has decreased from 10.55 (Mar 24) to 8.42, marking a decrease of 2.13.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.41. This value is within the healthy range. It has decreased from 10.55 (Mar 24) to 8.41, marking a decrease of 2.14.
- For Return on Networth / Equity (%), as of Mar 25, the value is 12.93. This value is below the healthy minimum of 15. It has decreased from 16.90 (Mar 24) to 12.93, marking a decrease of 3.97.
- For Return on Capital Employeed (%), as of Mar 25, the value is 14.42. This value is within the healthy range. It has decreased from 19.46 (Mar 24) to 14.42, marking a decrease of 5.04.
- For Return On Assets (%), as of Mar 25, the value is 9.03. This value is within the healthy range. It has decreased from 13.30 (Mar 24) to 9.03, marking a decrease of 4.27.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.19. This value is below the healthy minimum of 0.2. It has increased from 0.04 (Mar 24) to 0.19, marking an increase of 0.15.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.21. This value is within the healthy range. It has increased from 0.04 (Mar 24) to 0.21, marking an increase of 0.17.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.20. It has decreased from 1.37 (Mar 24) to 1.20, marking a decrease of 0.17.
- For Current Ratio (X), as of Mar 25, the value is 3.57. This value exceeds the healthy maximum of 3. It has decreased from 3.62 (Mar 24) to 3.57, marking a decrease of 0.05.
- For Quick Ratio (X), as of Mar 25, the value is 2.57. This value exceeds the healthy maximum of 2. It has decreased from 2.65 (Mar 24) to 2.57, marking a decrease of 0.08.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.82. This value exceeds the healthy maximum of 8. It has increased from 6.67 (Mar 24) to 9.82, marking an increase of 3.15.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 14.67. This value is below the healthy minimum of 20. It has increased from 12.61 (Mar 24) to 14.67, marking an increase of 2.06.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 11.45. This value is below the healthy minimum of 20. It has increased from 10.47 (Mar 24) to 11.45, marking an increase of 0.98.
- For Earning Retention Ratio (%), as of Mar 25, the value is 85.33. This value exceeds the healthy maximum of 70. It has decreased from 87.39 (Mar 24) to 85.33, marking a decrease of 2.06.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 88.55. This value exceeds the healthy maximum of 70. It has decreased from 89.53 (Mar 24) to 88.55, marking a decrease of 0.98.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 42.75. This value is within the healthy range. It has decreased from 101.38 (Mar 24) to 42.75, marking a decrease of 58.63.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 26.36. This value is within the healthy range. It has decreased from 62.80 (Mar 24) to 26.36, marking a decrease of 36.44.
- For Enterprise Value (Cr.), as of Mar 25, the value is 27,844.67. It has decreased from 28,716.86 (Mar 24) to 27,844.67, marking a decrease of 872.19.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.36. This value exceeds the healthy maximum of 3. It has decreased from 3.74 (Mar 24) to 3.36, marking a decrease of 0.38.
- For EV / EBITDA (X), as of Mar 25, the value is 23.68. This value exceeds the healthy maximum of 15. It has decreased from 23.94 (Mar 24) to 23.68, marking a decrease of 0.26.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.27. This value exceeds the healthy maximum of 3. It has decreased from 3.77 (Mar 24) to 3.27, marking a decrease of 0.50.
- For Retention Ratios (%), as of Mar 25, the value is 85.32. This value exceeds the healthy maximum of 70. It has decreased from 87.38 (Mar 24) to 85.32, marking a decrease of 2.06.
- For Price / BV (X), as of Mar 25, the value is 5.02. This value exceeds the healthy maximum of 3. It has decreased from 6.03 (Mar 24) to 5.02, marking a decrease of 1.01.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.27. This value exceeds the healthy maximum of 3. It has decreased from 3.77 (Mar 24) to 3.27, marking a decrease of 0.50.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Deepak Nitrite Ltd:
- Net Profit Margin: 8.42%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 14.42% (Industry Average ROCE: 13.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 12.93% (Industry Average ROE: 10.65%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 26.36
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.57
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 43.9 (Industry average Stock P/E: 161.14)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.21
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8.42%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Inorganic - Others | 2nd Floor, Fermenter House, Alembic City, Vadodra Gujarat 390003 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Deepak C Mehta | Chairman & Managing Director |
| Mr. Maulik D Mehta | Executive Director & CEO |
| Mr. Sanjay Upadhyay | Director & Group CFO |
| Mr. Ajay C Mehta | Non Executive Director |
| Mr. Meghav Mehta | Non Executive Director |
| Mr. Girish Satarkar | Executive Director |
| Mr. Vipul Shah | Independent Director |
| Mr. Punit Lalbhai | Independent Director |
| Mrs. Purvi Sheth | Independent Director |
| Mr. Sanjay Asher | Independent Director |
| Mr. Dileep Choksi | Independent Director |
FAQ
What is the intrinsic value of Deepak Nitrite Ltd?
Deepak Nitrite Ltd's intrinsic value (as of 03 January 2026) is ₹1909.62 which is 11.61% higher the current market price of ₹1,711.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹23,325 Cr. market cap, FY2025-2026 high/low of ₹2,527/1,513, reserves of ₹5,488 Cr, and liabilities of ₹7,884 Cr.
What is the Market Cap of Deepak Nitrite Ltd?
The Market Cap of Deepak Nitrite Ltd is 23,325 Cr..
What is the current Stock Price of Deepak Nitrite Ltd as on 03 January 2026?
The current stock price of Deepak Nitrite Ltd as on 03 January 2026 is ₹1,711.
What is the High / Low of Deepak Nitrite Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Deepak Nitrite Ltd stocks is ₹2,527/1,513.
What is the Stock P/E of Deepak Nitrite Ltd?
The Stock P/E of Deepak Nitrite Ltd is 43.9.
What is the Book Value of Deepak Nitrite Ltd?
The Book Value of Deepak Nitrite Ltd is 404.
What is the Dividend Yield of Deepak Nitrite Ltd?
The Dividend Yield of Deepak Nitrite Ltd is 0.44 %.
What is the ROCE of Deepak Nitrite Ltd?
The ROCE of Deepak Nitrite Ltd is 16.3 %.
What is the ROE of Deepak Nitrite Ltd?
The ROE of Deepak Nitrite Ltd is 13.4 %.
What is the Face Value of Deepak Nitrite Ltd?
The Face Value of Deepak Nitrite Ltd is 2.00.